DGM
Darwin Global Management Portfolio holdings
AUM
$2.38B
This Quarter Return
+6.86%
1 Year Return
+81.43%
3 Year Return
+6,053.69%
5 Year Return
–
10 Year Return
–
AUM
$284M
AUM Growth
+$284M
(-54%)
Cap. Flow
-$273M
Cap. Flow
% of AUM
-95.94%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
1
Increased
–
Reduced
1
Closed
1
Top Buys
| 1 |
Immunovant
IMVT
|
$69.8M |
Top Sells
| 1 |
TG Therapeutics
TGTX
|
$230M |
| 2 |
argenx
ARGX
|
$112M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMAM
1
DELISTED
Ambrx Biopharma, Inc. Common Stock
AMAM
| $192M | 67.54% | 16,688,636 | – | – |
|
|
2
Immunovant
IMVT
$2.56B
| $69.8M | 24.57% | +1,818,371 | New | +$69.8M |
|
|
3
argenx
ARGX
$43.6B
| $22.4M | 7.89% | 45,615 -227,728 | -83% | -$112M |
|
|
4
TG Therapeutics
TGTX
$4.65B
| – | – | -9,278,439 | Closed | -$230M |
|